Stock listing
gettex:5J90 Fluicell AB Aktie
German listing (gettex) of Fluicell AB · home listing Stockholm:FLUI
Follow Fluicell AB into a list and get an email when it puts out news.
Home listing price · OMXSTO:FLUI
21.10 SEK -1.90 (-8.3%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXSTO:FLUI
Past year +81.9% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits- Day range
- 20.80 – 22.80 SEKNov 20, 2026
- Volume
- 979 sharesNov 20, 2026
- Market cap
- 28.99M SEKAt the close on Nov 20, 2026 · price × 1.37M shares outstanding
- 52-week range
- 7.65 – 67.20 SEKLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- 157,400 SEKMedian day 3,104 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|
| Stockholm:FLUI · Home | 21.10 SEK | -1.90 (-8.3%) | 979 | 20.80 | 22.80 | 20.80 | 23.00 | Close on Nov 20, 2026 |
|---|
| Frankfurt:5J90 | €1.83 EUR | -0.18 (-9.0%) | — | €1.89 | €1.89 | €1.83 | €2.01 | Close on Nov 20, 2026 |
|---|
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OMXSTO:FLUI · SEK, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|
| 21.10 | -1.90 | -8.3% | 20.80 | 22.80 | 20.80 | 979 |
|---|
| 23.00 | -0.90 | -3.8% | 23.90 | 23.90 | 23.00 | 1,218 |
|---|
| 23.90 | -0.30 | -1.2% | 22.30 | 25.90 | 22.30 | 1,651 |
|---|
| 24.20 | -2.00 | -7.6% | 25.20 | 25.70 | 22.00 | 6,204 |
|---|
| 26.20 | -1.60 | -5.8% | 27.80 | 27.80 | 23.20 | 9,447 |
|---|
| 27.80 | -0.80 | -2.8% | 28.50 | 28.50 | 24.60 | 2,474 |
|---|
| 28.60 | +0.60 | +2.1% | 26.40 | 29.00 | 26.40 | 2,216 |
|---|
| 28.00 | +1.90 | +7.3% | 25.90 | 28.00 | 25.10 | 1,713 |
|---|
| 26.10 | -0.60 | -2.2% | 26.60 | 27.20 | 24.50 | 3,049 |
|---|
| 26.70 | -0.60 | -2.2% | 27.40 | 27.40 | 23.50 | 3,862 |
|---|
| 27.30 | +1.10 | +4.2% | 27.90 | 28.10 | 27.00 | 831 |
|---|
| 26.20 | -1.70 | -6.1% | 27.30 | 29.40 | 26.10 | 5,552 |
|---|
| 27.90 | +0.20 | +0.7% | 27.70 | 27.90 | 27.70 | 286 |
|---|
| 27.70 | -0.10 | -0.4% | 28.70 | 28.70 | 27.70 | 3,393 |
|---|
| 27.80 | +0.60 | +2.2% | 27.10 | 28.90 | 27.10 | 3,442 |
|---|
| 27.20 | -0.30 | -1.1% | 27.10 | 28.00 | 27.10 | 925 |
|---|
| 27.50 | +0.30 | +1.1% | 27.20 | 28.00 | 26.30 | 871 |
|---|
| 27.20 | +0.70 | +2.6% | 27.50 | 29.00 | 27.20 | 2,721 |
|---|
| 26.50 | -0.60 | -2.2% | 27.40 | 28.00 | 26.50 | 1,671 |
|---|
| 27.10 | -1.00 | -3.6% | 28.10 | 28.10 | 27.10 | 456 |
|---|
| 28.10 | -0.10 | -0.4% | 27.40 | 28.70 | 26.80 | 903 |
|---|
| 28.20 | -0.30 | -1.1% | 27.80 | 28.30 | 27.40 | 1,303 |
|---|
| 28.50 | +0.80 | +2.9% | 28.30 | 28.60 | 27.20 | 1,731 |
|---|
| 27.70 | +1.30 | +4.9% | 26.10 | 27.70 | 26.10 | 2,799 |
|---|
| 26.40 | -1.70 | -6.0% | 28.40 | 29.00 | 25.30 | 5,561 |
|---|
| 28.10 | +0.40 | +1.4% | 27.70 | 28.10 | 26.60 | 1,908 |
|---|
| 27.70 | -1.00 | -3.5% | 28.70 | 28.70 | 27.70 | 2,714 |
|---|
| 28.70 | -0.40 | -1.4% | 29.10 | 29.20 | 28.00 | 3,054 |
|---|
| 29.10 | -0.10 | -0.3% | 29.20 | 31.90 | 29.10 | 2,557 |
|---|
| 29.20 | -0.70 | -2.3% | 29.90 | 30.90 | 29.20 | 2,802 |
|---|
| 29.90 | +0.70 | +2.4% | 30.00 | 30.90 | 29.20 | 3,086 |
|---|
| 29.20 | -0.80 | -2.7% | 29.30 | 30.00 | 29.10 | 920 |
|---|
| 30.00 | +0.70 | +2.4% | 29.60 | 31.10 | 29.20 | 3,431 |
|---|
| 29.30 | 0.00 | 0.0% | 29.60 | 30.40 | 29.30 | 1,842 |
|---|
| 29.30 | -0.80 | -2.7% | 30.30 | 30.30 | 29.30 | 3,800 |
|---|
| 30.10 | +0.30 | +1.0% | 29.50 | 31.40 | 29.50 | 857 |
|---|
| 29.80 | +0.20 | +0.7% | 30.40 | 30.40 | 29.40 | 3,097 |
|---|
| 29.60 | -0.70 | -2.3% | 29.20 | 31.20 | 29.20 | 2,452 |
|---|
| 30.30 | 0.00 | 0.0% | 30.30 | 30.30 | 29.00 | 5,186 |
|---|
| 30.30 | -0.10 | -0.3% | 30.40 | 30.70 | 29.30 | 1,768 |
|---|
| 30.40 | -0.60 | -1.9% | 31.00 | 31.00 | 29.60 | 7,467 |
|---|
| 31.00 | -0.40 | -1.3% | 31.00 | 32.00 | 30.30 | 8,606 |
|---|
| 31.40 | -0.10 | -0.3% | 31.40 | 32.40 | 30.20 | 6,059 |
|---|
| 31.50 | -1.40 | -4.3% | 32.90 | 33.30 | 30.70 | 6,351 |
|---|
| 32.90 | +0.10 | +0.3% | 32.80 | 32.90 | 30.70 | 2,723 |
|---|
| 32.80 | -0.60 | -1.8% | 30.60 | 32.90 | 30.60 | 5,777 |
|---|
| 33.40 | 0.00 | 0.0% | 33.50 | 33.70 | 31.90 | 3,713 |
|---|
| 33.40 | +1.00 | +3.1% | 32.40 | 33.70 | 31.80 | 10,691 |
|---|
| 32.40 | +2.70 | +9.1% | 29.70 | 34.10 | 29.70 | 29,108 |
|---|
| 29.70 | -0.40 | -1.3% | 29.50 | 30.40 | 29.10 | 6,875 |
|---|
| 30.10 | -0.30 | -1.0% | 29.90 | 30.30 | 28.40 | 3,110 |
|---|
| 30.40 | -0.90 | -2.9% | 31.40 | 31.40 | 29.50 | 5,824 |
|---|
| 31.30 | 0.00 | 0.0% | 31.40 | 31.90 | 30.40 | 4,423 |
|---|
| 31.30 | +0.60 | +2.0% | 31.30 | 31.40 | 29.90 | 4,340 |
|---|
| 30.70 | 0.00 | 0.0% | 31.00 | 31.40 | 30.70 | 2,257 |
|---|
| 30.70 | +0.60 | +2.0% | 30.40 | 30.90 | 30.00 | 4,809 |
|---|
| 30.10 | -1.80 | -5.6% | 31.00 | 31.90 | 30.00 | 9,840 |
|---|
| 31.90 | -4.10 | -11.4% | 40.10 | 43.00 | 29.00 | 51,711 |
|---|
| 36.00 | +0.90 | +2.6% | 33.80 | 37.00 | 32.30 | 11,043 |
|---|
| 35.10 | +0.50 | +1.4% | 34.60 | 35.70 | 33.00 | 9,331 |
|---|
| 34.60 | +2.60 | +8.1% | 32.90 | 35.00 | 31.20 | 13,536 |
|---|
| 32.00 | -0.90 | -2.7% | 32.90 | 33.90 | 31.20 | 3,279 |
|---|
| 32.90 | +1.50 | +4.8% | 31.80 | 33.60 | 31.80 | 5,989 |
|---|
| 31.40 | +1.30 | +4.3% | 30.80 | 34.30 | 30.60 | 5,976 |
|---|
Splits
1 split · OMXSTO:FLUI · every price before a split is adjusted for it
| Day | Ratio | What |
|---|
| 1-for-350 | Consolidation |
|---|
- Ticker
- gettex:5J90
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- gettex
- Currency
- EUR
Fluicell AB on 6ix
- News releases
- 3 in all · newest Sep 2, 2025 · oldest 2020
- Decks
- 1 deck · latest May 22, 2023
Where Fluicell AB is listed
Valuation
EV/sales 1.6× against a median of 26.9×: 3rd lowest of 5 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- 30.96M SEK
- P/E
- 10.4×
- EV/sales
- 1.6×
- EV/EBITDA
- 10.7×
- Price/book
- 1.8×
- Gross margin
- 91.6%
- Operating margin
- 12.9%
- Net margin
- 14.1%
- Debt to equity
- 0.1×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|
| Fluicell AB · OMXSTO:FLUI | US$2.83M | US$3.03M | 10.4× | 1.6× | 10.7× | 1.8× | 14.1% | 0.1× | n/a |
|---|
| Skye Bioscience, Inc. · NASDAQ:SKYE | US$3.10M | −US$1.71M | n/a | n/a | n/a | 2.3× | n/a | 0.0× | 0.85 |
|---|
| Creative Medical Technology Holdings, Inc. · NASDAQ:CELZ | US$3.06M | −US$3.79M | n/a | −1,263× | n/a | 0.4× | n/a | 0.0× | 1.53 |
|---|
| Oncology Pharma Inc. · OTC:ONPH | US$3.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.62 |
|---|
| Imunon, Inc. · NASDAQ:IMNN | US$3.00M | US$5.90M | n/a | n/a | n/a | 1.1× | n/a | 2.6× | 0.57 |
|---|
| Gelteq Limited · NASDAQ:GELS | US$2.89M | US$6.27M | n/a | 57.2× | n/a | 0.3× | n/a | 0.4× | 0.83 |
|---|
| Curis, Inc. · NASDAQ:CRIS | US$2.85M | −US$1.42M | n/a | n/a | n/a | 1.1× | n/a | 0.3× | 1.85 |
|---|
| Alligator Bioscience AB · OMXSTO:ATORX | US$2.79M | US$1.47M | n/a | 53.3× | n/a | 1.2× | n/a | 1.2× | n/a |
|---|
| Traws Pharma, Inc. · NASDAQ:TRAW | US$2.69M | US$351,448 | n/a | n/a | n/a | n/a | n/a | n/a | 2.07 |
|---|
| NextCell Pharma AB · OMXSTO:NXTCL | US$2.69M | US$626,140 | n/a | 0.6× | n/a | 0.6× | −440.8% | 0.0× | n/a |
|---|
| Bioxytran, Inc. · OTC:BIXT | US$2.66M | US$2.59M | n/a | n/a | n/a | n/a | n/a | n/a | -1.20 |
|---|
| Median of the others | US$2.87M | US$626,140 | | 26.9× | | 1.1× | −440.8% | 0.3× | 1.19 |
|---|
Team and board
Officers
| Officer | Role |
|---|
| Carolina Trkulja | CEO |
|---|
| Joakim Wahlberg | Chief Financial Officer |
|---|
| Gavin D. M. Jeffries | CHIEF TECHNOLOGY OFFICER |
|---|
| Jonas Hannestad | CHIEF MARKETING & COMMUNICATIONS OFFICER |
|---|
| Vladimir Kirejev | Senior R&D Scientist and Laboratory Manager |
|---|
Board
| Director | Role |
|---|
| Niklas Frisk | Chairman of the board |
|---|
| Abdul Kader | Board member |
|---|
| Alex Scheepers | Board member |
|---|
| Carl Fhager | Board member |
|---|
| Daniel T. Chiu | Board member |
|---|
| Karin Jennbacken | Board member |
|---|
| Owe Orwar | Board member |
|---|
| Peter Kjäll | Board member |
|---|
Events
| Quarter | Results | Share move |
|---|
| Q1 2024 | May 16, 2024 · After close | +1.8% |
|---|
| Q4 2023 | Jan 4, 2024 · After close | +3.3% |
|---|
Open Events
Financials
Annual, in SEK
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|
| Revenue | 6.00M | 1.86M | 3.34M | 3.25M | 2.60M | 4.63M | 2.49M | 1.23M | 1.05M | 2.63M |
|---|
| Cost of revenue | 14.7M | 1.59M | 1.60M | 663.0K | 715.0K | 988.0K | 443.0K | 391.0K | 8.49M | 7.59M |
|---|
| Gross profit | -8.69M | 3.76M | 1.74M | 2.59M | 1.89M | 3.65M | 2.04M | 835.0K | -7.44M | -4.96M |
|---|
| Selling, general and administrative | 11.9M | 14.4M | 18.6M | 16.9M | 9.94M | 7.13M | 8.32M | 7.43M | 3.96M | 4.65M |
|---|
| Operating income | -8.69M | -15.8M | -26.9M | -21.7M | -21.7M | -17.0M | -18.7M | -14.8M | -7.44M | -4.97M |
|---|
| Depreciation and amortization | 370.0K | 440.0K | 610.0K | 720.0K | 588.0K | 605.0K | 522.0K | 326.0K | 71.0K | 85.0K |
|---|
| EBITDA | -8.31M | -15.4M | -26.3M | -21.0M | -21.1M | -16.4M | -18.2M | -14.5M | -7.37M | -4.88M |
|---|
| Interest expense | 193.0K | 79.0K | 30.0K | 47.0K | 27.0K | 564.0K | 421.0K | 2.00K | 34.0K | 27.0K |
|---|
| Income before tax | -8.33M | -15.5M | -26.6M | -21.6M | -21.7M | -17.6M | -18.6M | -14.7M | -7.47M | -4.95M |
|---|
| Income tax | | | 442.1K | -120.0K | 27.0K | 564.0K | 398.1K | -78.0K | 34.0K | -16.0K |
|---|
| Net income | -8.33M | -15.5M | -26.6M | -21.5M | -21.7M | -18.2M | -18.6M | -14.7M | -7.47M | -4.95M |
|---|
| Earnings per share, basic | -6.07 | -13.10 | -25.45 | -0.32 | -0.37 | -0.33 | -62.24 | -52.95 | -35.86 | -37.72 |
|---|
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|
| Cash and equivalents | 2.26M | 15.9M | 2.76M | 24.5M | 20.7M | 18.8M | 8.44M | 22.2M | 7.83M | 1.10M |
|---|
| Receivables | 2.20M | 1.38M | 1.24M | 2.79M | 1.93M | 1.77M | 1.67M | 529.0K | 1.44M | 820.0K |
|---|
| Inventory | 3.04M | 3.35M | 3.15M | 1.55M | 1.84M | 1.91M | 818.0K | 936.0K | 877.0K | 443.0K |
|---|
| Current assets | 7.60M | 20.7M | 7.61M | 29.2M | 24.8M | 22.9M | 11.3M | 24.0M | 10.8M | 2.50M |
|---|
| Property, plant and equipment | 445.0K | 1.14M | 1.54M | 2.30M | 1.84M | 1.60M | 1.83M | 1.49M | 206.0K | 273.0K |
|---|
| Total assets | 18.5M | 25.5M | 9.34M | 31.8M | 27.0M | 24.8M | 19.9M | 26.0M | 11.5M | 2.77M |
|---|
| Accounts payable | 1.30M | 897.0K | 1.50M | 858.0K | 1.05M | 736.0K | 1.87M | 854.0K | 759.0K | 226.0K |
|---|
| Current liabilities | 7.57M | 6.05M | 8.91M | 8.32M | 7.87M | 5.33M | 9.71M | 2.60M | 1.95M | 861.0K |
|---|
| Long-term debt | | | | | | | | | 0 | |
|---|
| Total debt | | | | | | | 5.00M | | 73.0K | 220.0K |
|---|
| Total liabilities | 7.57M | 6.27M | 8.91M | 8.32M | 7.87M | 5.33M | 9.71M | 2.60M | 1.95M | 934.0K |
|---|
| Shareholders' equity | 10.9M | 19.2M | 425.0K | 23.4M | 19.1M | 19.5M | 10.2M | 23.4M | 9.58M | 1.84M |
|---|
| Shares outstanding | 1.37M | 1.18M | 1.04M | 67.7M | 59.2M | 55.1M | 299.4K | 277.6K | 208.3K | 131.2K |
|---|
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|
| Cash from operations | -4.95M | -15.7M | -27.2M | -21.0M | -18.6M | -17.6M | -17.1M | -12.5M | -7.83M | -5.50M |
|---|
| Capital spending | -4.95M | -3.49M | 0 | -1.14M | -772.0K | -331.0K | -812.0K | -1.56M | -500.0K | -83.0K |
|---|
| Free cash flow | -13.6M | -15.7M | -27.2M | -22.2M | -19.4M | -17.9M | -17.9M | -14.0M | -8.33M | -5.58M |
|---|
| Cash from investing | -8.67M | -3.49M | 0 | -1.14M | -772.0K | -331.0K | -812.0K | -1.56M | -500.0K | -83.0K |
|---|
| Cash from financing | 0 | 32.3M | 5.53M | 25.9M | 21.3M | 28.3M | 4.09M | 28.4M | 15.1M | 5.93M |
|---|
| Dividends paid | | | | | | | -5.00M | | | |
|---|
| Share buybacks | 0 | 39.5M | 3.87M | 31.7M | 23.2M | 30.8M | -6.40M | 33.7M | 16.4M | 6.10K |
|---|
| Change in cash | -13.7M | 13.2M | -21.7M | 3.76M | 1.89M | 10.4M | -13.8M | 14.4M | 6.73M | 353.0K |
|---|
Open Financials
Cap table
Built by 6ix from Fluicell AB’s releases
- Common shares
- 1,373,703
- Fully diluted
- 1,373,703
Fully diluted
| Line | Shares |
|---|
| Common shares | 1,373,703 |
|---|
Share count over time
| Count | Shares |
|---|
| Nov 22, 2026 | 1,373,703 |
|---|
Open Cap table
Shareholders
| Trade | Trade | Shares | Price | Value | Date |
|---|
| Joakim Wahlberg Chief Financial Officer (CFO) | Buy | 204 | SEK 11.00 | SEK 2,244 | Mar 13, 2026 |
|---|
| Joakim Wahlberg Chief Financial Officer (CFO) | Buy | 600 | SEK 11.00 | SEK 6,600 | Mar 6, 2026 |
|---|
| Joakim Wahlberg Chief Financial Officer (CFO) | Buy | 39 | SEK 10.91 | SEK 425 | Mar 5, 2026 |
|---|
| Joakim Wahlberg Chief Financial Officer (CFO) | Buy | 1,000 | SEK 10.20 | SEK 10,200 | Jan 19, 2026 |
|---|
| Joakim Wahlberg Chief Financial Officer (CFO) | Buy | 1,000 | SEK 10.50 | SEK 10,500 | Jan 13, 2026 |
|---|
| Joakim Wahlberg Chief Financial Officer (CFO) | Buy | 7 | SEK 10.20 | SEK 71 | Jan 12, 2026 |
|---|
| Joakim Wahlberg Chief Financial Officer (CFO) | Buy | 1,000 | SEK 10.30 | SEK 10,300 | Dec 9, 2025 |
|---|
Open Shareholders
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|
| Abdul Kader | Board member · Since at least Nov 5, 2026 |
|---|
| Alex Scheepers | Board member · Since at least Nov 4, 2026 |
|---|
| Carl Fhager | Board member · Since at least Nov 5, 2026 |
|---|
| Carolina Trkulja | CEO · Since at least Nov 5, 2026 |
|---|
| Daniel T. Chiu | Board member · Since at least Nov 5, 2026 |
|---|
| Gavin D. M. Jeffries | CHIEF TECHNOLOGY OFFICER · Since at least Nov 5, 2026 |
|---|
| Joakim Wahlberg | Chief Financial Officer · Since at least Nov 5, 2026 |
|---|
| Jonas Hannestad | CHIEF MARKETING & COMMUNICATIONS OFFICER · Since at least Nov 5, 2026 |
|---|
| Karin Jennbacken | Board member · Since at least Nov 5, 2026 |
|---|
| Niklas Frisk | Chairman of the board · Since at least Nov 5, 2026 |
|---|
All 13 people
| Person | Seat |
|---|
| Owe Orwar | Board member · Since at least Nov 5, 2026 |
|---|
| Peter Kjäll | Board member · Since at least Nov 5, 2026 |
|---|
| Vladimir Kirejev | Senior R&D Scientist and Laboratory Manager · Since at least Nov 5, 2026 |
|---|
Open People
Log in to ask 6ix AI your own questions about Fluicell AB.